在刑事司法系统中治疗阿片类药物使用障碍和相关传染病。
Treating Opioid Use Disorder and Related Infectious Diseases in the Criminal Justice System.
机构信息
Division of Infectious Diseases, Department of Internal Medicine, Columbia University Irving Medical Center, 622 West 168th Street, PH 8 W-876, New York, NY 10032, USA; HIV Center for Clinical and Behavioral Studies at Columbia University and New York State Psychiatric Institute, New York, NY, USA.
Department of Internal Medicine, Montefiore Medical Center, 305 East 161th Street, Room 4, Bronx, NY, USA.
出版信息
Infect Dis Clin North Am. 2020 Sep;34(3):585-603. doi: 10.1016/j.idc.2020.06.012.
Abstract
This article provides an overview of the diagnosis and management of opioid use disorder and its infectious complications among populations with criminal justice involvement. Opioid use disorder and chronic infections such as human immunodeficiency virus and hepatitis C virus are highly prevalent among incarcerated individuals and some of the unique features of correctional facilities present challenges for their appropriate medical management. We outline evidence-based strategies for integrated, patient-centered treatment during incarceration and the potentially hazardous transition back to the community upon release.
摘要
本文概述了具有刑事司法涉案经历的人群中阿片类药物使用障碍及其感染性并发症的诊断和管理。阿片类药物使用障碍和慢性感染（如人类免疫缺陷病毒和丙型肝炎病毒）在被监禁者中非常普遍，而监管设施的一些独特特征给他们的适当医疗管理带来了挑战。我们概述了在监禁期间进行综合、以患者为中心的治疗的循证策略，以及在释放后返回社区时可能存在的危险过渡。
相似文献
1
Treating Opioid Use Disorder and Related Infectious Diseases in the Criminal Justice System.在刑事司法系统中治疗阿片类药物使用障碍和相关传染病。
Infect Dis Clin North Am. 2020 Sep;34(3):585-603. doi: 10.1016/j.idc.2020.06.012.
2
The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons: A Systematic Review.药物治疗阿片类药物使用障碍对监禁人群丙型肝炎发病率的影响：系统评价。
Infect Dis Clin North Am. 2020 Sep;34(3):559-584. doi: 10.1016/j.idc.2020.06.011.
3
Interventions for incarcerated adults with opioid use disorder in the United States: A systematic review with a focus on social determinants of health.美国监禁的阿片类药物使用障碍成年患者的干预措施：一项系统评价，重点关注健康的社会决定因素。
PLoS One. 2020 Jan 21;15(1):e0227968. doi: 10.1371/journal.pone.0227968. eCollection 2020.
4
Criminal justice continuum for opioid users at risk of overdose.阿片类药物使用者面临药物过量风险的刑事司法连续统。
Addict Behav. 2018 Nov;86:104-110. doi: 10.1016/j.addbeh.2018.02.024. Epub 2018 Feb 24.
5
Opioid Use Among Those Who Have Criminal Justice Experience: Harm Reduction Strategies to Lessen HIV Risk.有刑事司法经验者的阿片类药物使用：降低 HIV 风险的减少伤害策略。
Curr HIV/AIDS Rep. 2018 Jun;15(3):255-258. doi: 10.1007/s11904-018-0394-z.
6
Criminal justice outcomes over 5 years after randomization to buprenorphine-naloxone or methadone treatment for opioid use disorder.随机分配到丁丙诺啡-纳洛酮或美沙酮治疗阿片类药物使用障碍 5 年后的刑事司法结局。
Addiction. 2019 Aug;114(8):1396-1404. doi: 10.1111/add.14620. Epub 2019 May 2.
7
Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.监禁人员中与阿片类药物相关的治疗、干预措施和结果：系统评价。
PLoS Med. 2019 Dec 31;16(12):e1003002. doi: 10.1371/journal.pmed.1003002. eCollection 2019 Dec.
8
Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions.将有犯罪记录的个体在释放到社区后与 HIV、丙型肝炎和阿片类药物使用障碍预防和治疗服务联系起来：进展、差距和未来方向。
Int J Drug Policy. 2021 Oct;96:103283. doi: 10.1016/j.drugpo.2021.103283. Epub 2021 May 18.
9
Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.出狱后对纳曲酮、美沙酮和丁丙诺啡延长释放治疗的看法。
Addict Sci Clin Pract. 2019 Oct 1;14(1):37. doi: 10.1186/s13722-019-0166-0.
10
Recent incarceration and buprenorphine maintenance treatment outcomes among human immunodeficiency virus-positive patients.近期监禁与丁丙诺啡维持治疗对艾滋病毒阳性患者的影响。
Subst Abus. 2017 Jul-Sep;38(3):297-302. doi: 10.1080/08897077.2016.1220443. Epub 2016 Aug 11.
引用本文的文献
1
Opioid-related harms and experiences of care among people in justice settings in New South Wales, Australia: evidence from the National Ambulance Surveillance System.澳大利亚新南威尔士州司法环境中与阿片类药物相关的危害及护理体验：来自国家救护车监测系统的证据
Harm Reduct J. 2025 Jan 15;22(1):8. doi: 10.1186/s12954-025-01154-7.
2
Influences of the criminal justice system on use of medications for opioid use disorder: a qualitative study.刑事司法系统对阿片类物质使用障碍药物使用的影响：一项定性研究
BMC Glob Public Health. 2024 Sep 19;2(1):64. doi: 10.1186/s44263-024-00093-y.
3
Racial Differences in Self-Report of Mental Illness and Mental Illness Treatment in the Community: An Analysis of Jail Intake Data.社区中自我报告的精神疾病和精神疾病治疗的种族差异：监狱收容数据分析。
Adm Policy Ment Health. 2023 Nov;50(6):966-975. doi: 10.1007/s10488-023-01297-4. Epub 2023 Sep 21.
4
Negative attitudes about medications for opioid use disorder among criminal legal staff.刑事司法工作人员对阿片类物质使用障碍药物的负面态度。
Drug Alcohol Depend Rep. 2022 Apr 25;3:100056. doi: 10.1016/j.dadr.2022.100056. eCollection 2022 Jun.
本文引用的文献
1
The benefits and implementation challenges of the first state-wide comprehensive medication for addictions program in a unified jail and prison setting.首个全州范围内在统一的监狱环境中实施的成瘾性药物全面治疗方案的益处和实施挑战。
Drug Alcohol Depend. 2019 Dec 1;205:107514. doi: 10.1016/j.drugalcdep.2019.06.016. Epub 2019 Oct 7.
2
Linkage to hepatitis C care after incarceration in jail: a prospective, single arm clinical trial.监禁后与丙型肝炎护理的关联：一项前瞻性、单臂临床试验。
BMC Infect Dis. 2019 Aug 8;19(1):703. doi: 10.1186/s12879-019-4344-1.
3
Trauma-Informed Care: a Strategy to Improve Primary Healthcare Engagement for Persons with Criminal Justice System Involvement.创伤知情照护：提升有刑事司法系统介入经历者参与初级医疗照护的策略。
J Gen Intern Med. 2019 Jun;34(6):1048-1052. doi: 10.1007/s11606-018-4783-1. Epub 2019 Mar 25.
4
Effect of Patient Navigation on Transitions of HIV Care After Release from Prison: A Retrospective Cohort Study.患者导航对出狱后 HIV 护理转衔的影响：一项回顾性队列研究。
AIDS Behav. 2019 Sep;23(9):2549-2557. doi: 10.1007/s10461-019-02437-4.
5
Health, Polysubstance Use, and Criminal Justice Involvement Among Adults With Varying Levels of Opioid Use.健康、多种物质使用与不同程度阿片类药物使用的成年人的刑事司法涉入。
JAMA Netw Open. 2018 Jul 6;1(3):e180558. doi: 10.1001/jamanetworkopen.2018.0558.
6
Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.药物和阿片类药物滥用相关的过量死亡-美国，2013-2017 年。
MMWR Morb Mortal Wkly Rep. 2018 Jan 4;67(5152):1419-1427. doi: 10.15585/mmwr.mm675152e1.
7
Trends in Drug Use-Associated Infective Endocarditis and Heart Valve Surgery, 2007 to 2017: A Study of Statewide Discharge Data.2007 年至 2017 年药物滥用相关性感染性心内膜炎及心脏瓣膜手术趋势：全州出院数据研究。
Ann Intern Med. 2019 Jan 1;170(1):31-40. doi: 10.7326/M18-2124. Epub 2018 Dec 4.
8
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.监禁史与注射吸毒人群中 HIV 和丙型肝炎病毒感染风险：系统评价和荟萃分析。
Lancet Infect Dis. 2018 Dec;18(12):1397-1409. doi: 10.1016/S1473-3099(18)30469-9. Epub 2018 Oct 29.
9
Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use.2000-2017 年纽约市阿片类药物流行期间新注射吸毒者中的丙型肝炎病毒流行率和估计发病率：非注射吸毒的保护作用。
Drug Alcohol Depend. 2018 Nov 1;192:74-79. doi: 10.1016/j.drugalcdep.2018.07.034. Epub 2018 Sep 12.
10
HIV treatment outcomes among formerly incarcerated transitions clinic patients in a high prevalence setting.高流行环境下曾被监禁的转诊诊所患者的艾滋病毒治疗结果
Health Justice. 2018 Sep 17;6(1):16. doi: 10.1186/s40352-018-0074-5.
Zotero 插件